Nucynta ER is approved to treat neuropathic pain associated with diabetic peripheral neuropathy in adult patients. It is the only opioid approved by the FDA for DPN-associated neuropathic pain.
More Articles on Pain Management:
10 Pain Management Physicians on the Move
ASIPP Releases Guidelines on Opioid Prescriptions for Non-Cancer Pain Patients
Kansas University Hospital Addition Includes Pain Management
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.